Akero Therapeutics, Inc. Akero Therapeutics, Inc.

Akero Therapeutics, Inc.

AKRO

Rang în acțiuni #3735
Akero Therapeutics, Inc. is a biopharmaceutical firm dedicated to addressing... Akero Therapeutics, Inc. is a biopharmaceutical firm dedicated to addressing cardio-metabolic disorders, with a specific focus on nonalcoholic steatohepatitis (NASH). Its primary objective is the creation of therapeutic agents aimed at re-establishing metabolic equilibrium and enhancing overall well-being. The company's flagship investigational drug is efruxifermin (EFX), a synthetic analog of fibroblast growth factor 21. EFX is designed to shield cells from stress and modulate the systemic metabolism of fats, carbohydrates, and proteins throughout the body. This promising compound is currently undergoing evaluation in a Phase 2a clinical investigation, known as the BALANCED study, for individuals diagnosed with biopsy-confirmed NASH. Originally established as Pippin Pharmaceuticals, Inc., the organization rebranded as Akero Therapeutics, Inc. in May 2018. Founded in 2017, Akero Therapeutics maintains its corporate headquarters in South San Francisco, California.
Preț acțiune
$54.65
Ultima sincronizare: 2025-12-09
Capitalizare de piață
$4.50B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
1.37%
Țară
US
Tranzacționează Akero Therapeutics, Inc. (AKRO)

Categorie

Healthcare
Istoricul spliturilor pentru Akero Therapeutics, Inc. (AKRO)
Acțiunea Akero Therapeutics, Inc. (simbol: AKRO) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 20, 2026.
O acțiune AKRO cumpărată înainte de Oct 20, 2026 este echivalentă astăzi cu 0 acțiuni AKRO.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL